Viewing Study NCT06637306

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 1:16 PM
Ignite Modification Date: 2026-04-06 @ 3:05 PM
Study NCT ID: NCT06637306
Status: RECRUITING
Last Update Posted: 2025-03-26
First Post: 2024-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
Sponsor: Rima Patel
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Triple Negative Breast Cancer View
None TNBC - Triple-Negative Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dupilumab View
None Pembrolizumab View
None IL-4 Receptor Antagonist View
None Breast Cancer View
None Triple Negative View
None Locally Advanced View